Back to all studies
RecruitingNCT06830044

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

This recruiting study focuses on depression and currently lists sites or participation links in Bulgaria, Czechia, Poland, United States.

DepressionOtherFrom 18 Years to 65 Years
In plain English

Key information made simple

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. For people living with Depression, that matters because care needs to work in daily life, not just in theory. The findings could guide better understanding and future care, and taking part helps build that evidence for others.

What to expect

Your next step

The official record suggests in-person participation through a research setting, with sites including Vanda Investigational Site in Phoenix, Vanda Investigational Site in Little Rock, and Vanda Investigational Site in Garden Grove. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis, while common reasons not to take part include other factors that could make participation unsuitable. This is a later-stage study, which usually means a larger group and a closer look at how well the approach holds up.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT06830044. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Bulgaria.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com